We have more than 10 years of experience in custom synthesis of compounds. If you are looking for a supplier or manufacturer of lubiprostone (CAS No.: 136790-76-6) please contact us. We can provide customers with custom synthesis from grams to kilograms and the production of tons of compounds. Now, we also hope to meet your needs for lubiprostone (CAS No.: 136790-76-6) and other compounds. We can provide high-quality compounds and good service for you.
Name |
Lubiprostone |
Synonyms |
13,14-Dihydro-15-keto-PGD2;13,14-Dihydro-15-ketoprostadlandin D2;13,14-dihydro-15-keto-16,16-difluoro-Prostaglandin E1;9ALPHA-HYDROXY-11,15-DIOXO-PROST-5Z-EN-1-OIC ACID;13,14-dihydro-15-keto Prostaglandin D2 Lipid Maps MS Standard;DK-PGD2;13,14-dihydro-15-keto PD2;13,14-dihydro-15-keto-prostaglandin D2;13,14-dihydro-15-keto-16,16-difluoro-PGE1 |
Molecular Formula |
C20H32F2O5 |
Molecular Weight |
390.46200 |
CAS Number |
136790-76-6 |
purity |
≥98% |
Storage conditions |
Sealed in dry,Store in freezer, under -20°C |
application:Lubiprostone
(rINN, marketed under the trade name Amitiza among others)
(CAS No.: 136790-76-6) is a medication used in the management of
chronic idiopathic constipation, predominantly irritable bowel
syndrome-associated constipation in women and opioid-induced constipation.
It was initially approved by the U.S. Food and
Drug Administration (FDA) in 2006. It is very expensive as of 2012.